---
title: "Praxis Precision Medicines to report Q2 results, host conference call and webcast"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294407733.md"
description: "Praxis Precision Medicines will report Q2 2026 financial results for the period ended June 30, 2026, on August 6, 2026, before market open. A conference call and live webcast are scheduled for the same day at 8:30 a.m. ET via a registration link."
datetime: "2026-07-30T20:01:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294407733.md)
  - [en](https://longbridge.com/en/news/294407733.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294407733.md)
generator: "portal-rs"
---

# Praxis Precision Medicines to report Q2 results, host conference call and webcast

-   Praxis Precision Medicines will report Q2 results for the period ended June 30, 2026 on Aug. 6, 2026, before the open. \* Conference call, live webcast set for Aug. 6, 2026 at 8:30 a.m. ET via registration link (here). Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Praxis Precision Medicines Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607301601PRIMZONEFULLFEED9801165) on July 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [PRAX.US](https://longbridge.com/en/quote/PRAX.US.md)

## Related News & Research

- [NervGen to host inaugural R&D Day webcast on NVG-291 program](https://longbridge.com/en/news/298449939.md)
- [NGEx Minerals to host investor day webcast](https://longbridge.com/en/news/298297598.md)
- [BIC to webcast strategic plan update for 2030 targets](https://longbridge.com/en/news/298225164.md)
- [Arverne Group updates financial calendar with upcoming interim results release and investor webcast](https://longbridge.com/en/news/298346254.md)
- [Pyxis Oncology to webcast updated Phase 1 MICVO monotherapy data in recurrent/metastatic head and neck cancer](https://longbridge.com/en/news/298359153.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**